85-3105-28　Chlorogenic Acid 100g　CAS No:327-97-9　267501

特徴

• Chlorogenic acid is a derivative of caffeic acid and quinic acid; it has an antioxidant activity. Chlorogenic acid has been combined with gadolinium to develop a therapeutic and diagnostic nanodelivery system for MRI imaging. In a rat model of diabetes mellitus, chlorogenic acid counteracted the alterations in lipid profiles typical of type-2 diabetes, especially when administered in combination with tetrahydrocurcumin. In mice fed with a high-fat diet, the consumption of chlorogenic acid resulted in an anti-obesity action that lowered the blood levels of cholesterol and triglycerides. In humans, it is readily absorbed in the intestinal tract.
• Synonyms:(1S,3R,4R,5R)-3-[[3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyloxy]-1,4,5-trihydroxycyclohexanecarboxylic Acid; 3-(3,4-Dihydroxycinnamoyl)quinic Acid; 3-Caffeoylquinic Acid; 3-O-(3,4-Dihydroxycinnamoyl)-D-quinic Acid; 3-O-Caffeoylquinic Acid; Heriguard; NSC 407296; NSC 70861; [1S-(1α,3β,4α,5α)]-3-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyloxy]-1,4,5-trihydroxycyclohexanecarboxylic Acid; Caffetannic acid; Helianthic acid; Igasuric acid
• Molecular Formula:C16H18O9
• Molecular Weight:354.31
• Appearance:White to off-white powder
• Purity:≥98% (HPLC)
• Melting Point:192-195ºC
• Loss on Drying:≤5%
• Heavy Metals:≤0.001%
• Sulfate (SO42-):≤0.5%
• Chlorate (Cl-):≤0.0001%
• Phosphate (PO43-):≤0.0001%
• Lead (Pb):≤0.0001%
• Arsenic (As):≤0.0002%
• Cadmium (Cd):≤0.0001%
• Yeast and Mold:≤50cfu/g
• E. coli:Absent
• Pseudomonas aeruginosa:Absent
• Salmonella:Negative
• Staphylococcus aureus:Negative
• Mesh Size:100% pass 80 mesh
• Ash:≤3%
• Solubility:DMSO (Slightly), Methanol (Slightly)
• Storage and Stability:May be stored at RT for short-term only. Long-term storage is recommended at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap